Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 17911470)

1.

Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.

Galeazzi M, Bellisai F, Giannitti C, Manganelli S, Morozzi G, Sebastiani GD.

Ann N Y Acad Sci. 2007 Sep;1110:544-9. Review.

PMID:
17911470
2.

Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients.

Galeazzi M, Bellisai F, Manganelli S, Morozzi G, Sebastiani GD.

Autoimmun Rev. 2006 Aug;5(7):493-8. Epub 2006 Feb 20. Review.

PMID:
16920576
3.

Treatment of rheumatic diseases in patients with HCV and HIV infection.

Galeazzi M, Giannitti C, Manganelli S, Benucci M, Scarpato S, Bazzani C, Caporali R, Sebastiani GD.

Autoimmun Rev. 2008 Dec;8(2):100-3. doi: 10.1016/j.autrev.2008.07.009. Epub 2008 Aug 9. Review.

PMID:
18694850
4.

Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection?

Manna R, Verrecchia E, Fonnesu C, Giovinale M, De Socio G, Curigliano V, Cerquaglia C, Soriano A, Granata M, Migliore A, Massafra U, Gasbarrini G.

Eur Rev Med Pharmacol Sci. 2009 Mar;13 Suppl 1:63-9.

PMID:
19530514
5.

Treatment strategies for a patient with rheumatoid arthritis and hepatitis C.

Giannitti C, Bellisai F, Ferri C, Galeazzi M.

Expert Opin Pharmacother. 2009 Mar;10(4):579-87. doi: 10.1517/14656560902731951 . Review.

PMID:
19284361
6.

Hepatitis C-associated rheumatic disorders.

Buskila D.

Rheum Dis Clin North Am. 2009 Feb;35(1):111-23. doi: 10.1016/j.rdc.2009.03.005. Review.

PMID:
19481000
7.
8.

HCV infection: pathogenesis, clinical manifestations and therapy.

Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, Menegatti E, Olivieri I, Puoti M, Palazzi C, Roccatello D, Vergani D, Sarzi-Puttini P, Atzeni F.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S39-47. Review.

PMID:
18570753
9.

Cyclosporin in steroid-resistant autoimmune hepatitis and HCV-related liver diseases.

Fagiuoli S, Bruni F, Bravi M, Candusso M, Gaffuri G, Colledan M, Torre G.

Dig Liver Dis. 2007 Nov;39 Suppl 3:S379-85. doi: 10.1016/S1590-8658(07)60018-8. Review.

PMID:
18063259
10.

Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases.

Cavazzana I, Ceribelli A, Cattaneo R, Franceschini F.

Autoimmun Rev. 2008 Dec;8(2):104-6. doi: 10.1016/j.autrev.2008.05.002. Epub 2008 Jun 13.

PMID:
19014870
11.

Treatment of psoriasis with efalizumab in patients with hepatitis C viral infection: report of five cases.

Gisondi P, Prignano F, Grossi P, Lotti T, Girolomoni G.

Dermatology. 2009;219(2):158-61. doi: 10.1159/000224433. Epub 2009 Jun 9.

PMID:
19506351
12.

Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.

Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C, Triolo G, Valentini G, Valesini G; GISEA Group.

J Rheumatol. 2008 Oct;35(10):1944-9. Epub 2008 Aug 1.

PMID:
18688917
13.

Rheumatic disorders associated with hepatitis C.

Lövy MR, Starkebaum G.

Baillieres Best Pract Res Clin Rheumatol. 2000 Sep;14(3):535-57. Review.

PMID:
10985985
14.

[Rheumatic syndromes during the course of HCV infection].

Olesińska M, Chwalińska-Sadowska H.

Pol Merkur Lekarski. 2002 Feb;12(68):119-21. Polish.

PMID:
11995247
15.

Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.

Nanmoku K, Imaizumi R, Tojimbara T, Nakajima I, Fuchinoue S, Sakamoto N, Watanabe M, Teraoka S.

Transplant Proc. 2008 Sep;40(7):2382-5. doi: 10.1016/j.transproceed.2008.07.006.

PMID:
18790241
16.

Hepatitis C virus-related arthritis.

Palazzi C, D'Angelo S, Olivieri I.

Autoimmun Rev. 2008 Oct;8(1):48-51. doi: 10.1016/j.autrev.2008.07.025. Epub 2008 Aug 14. Review.

PMID:
18707027
17.

Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C.

Dizdar O, Tapan U, Aksoy S, Harputluoglu H, Kilickap S, Barista I.

Eur J Haematol. 2008 May;80(5):381-5. doi: 10.1111/j.1600-0609.2008.01039.x. Epub 2008 Jan 23. Review.

PMID:
18221389
18.
19.

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, Lin CL, Jeng YM, Chen PJ, Chen DS.

Gastroenterology. 2009 Feb;136(2):496-504.e3. doi: 10.1053/j.gastro.2008.10.049. Epub 2008 Oct 29.

PMID:
19084016
20.

[Cyclosporin in autoimmune diseases].

Follath F, Fontana A, Leumann E, Michel BA, Miescher PA, Schreier M, Schroeder M, Wenk M.

Schweiz Med Wochenschr. 1994 Jul 12;124(27-28):1232-9. Review. German.

PMID:
8052828
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk